Recently, blockage of PD-L1/PD-1 crosstalk using an anti-PD1 antibody has meant a revolutionary treatment for many types of tumors, such as melanoma, lung, and renal cancers (9, 36, 37). The gene discussed is CD274; the disease is renal carcinoma.